Before making a mammoth, ask the public
By Victoria Herridge,
Nature
| 10. 20. 2021
Image by Russ Seidel on Flickr
Every few years for the past 20 or so, the story resurfaces, frozen in time like a permafrost carcass. At some future point, typically within the decade, scientists hope to ‘bring back the mammoth’. There have been a few tantalizing results — stirrings in mammoth nuclei transplanted into mouse eggs (K. Yamagata et al. Sci. Rep. 9, 4050; 2019) — but that’s it. Hence raised eyebrows at last month’s announcement by de-extinction champion and geneticist George Church, co-founder (with entrepreneur Ben Lamm) of biotechnology start-up Colossal: yet again, the world has about five years until a wobbly, woolly calf takes its first steps into the Anthropocene.
What Colossal actually aims to produce is less a mammoth than a new synthetic species, a chimaera of Asian elephant DNA and mitochondria, mammoth genetic code and, from the probable surrogate dam, African elephant epigenetics. The resulting cold-adapted elephants — Colossal hopes — will trample and graze northern Siberia to create something akin to the Ice Age grasslands of the woolly mammoth’s heyday. Compacted...
Related Articles
By Adithi Ramakrishnan, AP News | 08.05.2026
NEW YORK (AP) — Matt Walker couldn’t pet a dog without sneezing — until he and other scientists used a gene editing technique to produce a hypoallergenic beagle named Bailey.
Now, he can feed Bailey spoons of peanut butter while...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...